openPR Logo
Press release

Drug Delivery Technologies Market Growth Factors 2024, Demand Supply Scenario, Size Estimates, Competitive Analysis and Forecast to 2031 | Glaxosmithkline PLC, Vectura Group Plc

05-20-2024 10:49 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Coherent Market Insights

Drug Delivery Technologies Market

Drug Delivery Technologies Market

Market Overview:

Drug delivery technologies provide sophisticated methods and platforms to safely deliver active pharmaceutical ingredients. This ensures drugs remain in the body for sufficient duration of time to achieve their desired therapeutic effects.

Market Dynamics:

Rising prevalence of chronic diseases such as cancer, cardiovascular diseases, diabetes, and respiratory disorders have significantly driven the demand for drug delivery technologies. According to the WHO, chronic diseases accounted for over 70% of all deaths globally in 2019. Further, changing lifestyle habits with increasing consumption of fast food, alcohol, and tobacco have augmented the risk of developing such conditions. Another key market driver is the growing geriatric population worldwide. People aged 65 years and above are more susceptible to chronic ailments and accordingly require efficient drug therapies. According to the UN data, the share of global population aged 65 years or above is projected to double from 7% to 16% between 2015 and 2050.

Request Exclusive Sample Copy of the Report at: - https://www.coherentmarketinsights.com/insight/request-sample/2690

Market Driver:

The growing prevalence of chronic diseases such as cancer, diabetes, cardiovascular diseases etc. across the world has been a key factor driving the demand for advanced drug delivery technologies. According to the World Health Organization, chronic diseases are estimated to account for around 60% of all deaths globally. Traditional drug delivery methods often face challenges in effectively targeting and delivering drugs for chronic conditions. Advanced drug delivery technologies allow for improved targeting of diseased areas, controlled release of drugs, and enhanced bioavailability which help achieve better therapeutic outcomes. This has encouraged pharmaceutical companies to invest heavily in developing novel drug delivery systems.

List of TOP Players in Market Report are: -

◘ 3M
◘ Bayer AG
◘ Becton
◘ Dickinson & Company
◘ Johnson & Johnson
◘ Pfizer Inc.
◘ Novartis AG
◘ Glaxosmithkline PLC
◘ Vectura Group Plc.
◘ Roche Holding AG
◘ Antares Pharma Inc.
◘ Alkermes
◘ Merck & Co. Inc
◘ Sanofi
◘ Aradigm Corp.

Note: Major Players are sorted in no particular order.

Market Detailed Segmentation:

On the basis of route of administration,

Oral
Parenteral
Intramuscular
Intravenous
Intra-Arterial
Subcutaneous route
Nasal Drug Delivery
Topical/Transdermal

On the basis of end user,

Ambulatory Surgical Clinics
Diagnostic Centers
Hospitals
Homecare
Others

Massive patent cliffs of blockbuster drugs over the past decade have put pressure on pharmaceutical firms to invest in innovative drug delivery technologies to compensate for revenue losses. When lucrative drugs lose patent protection, companies strive to extend their market monopoly through modified or specialized delivery systems of old molecules. Sustained-release formulations, drug-device combinations, and targeted delivery mechanisms allow drug makers to gain additional patent protection and market share. They help differentiate old drugs and command premium prices before generics capture significant market share. This market driver has emerged as a key growth strategy for large pharma companies facing patent expiration of their top-selling brands.

Market Restrain: High Development Costs

The development of advanced drug delivery technologies requires significant investments in R&D. Not only do drug delivery devices and systems add to production costs but extensive clinical testing is also needed to prove safety and efficacy of new delivery mechanisms. Unlike conventional drugs, delivery systems face additional regulatory hurdles. While novel delivery technologies promise several therapeutic advantages, the high costs associated with development, regulatory approval and manufacturing pose a major challenge. They increase the financial risk for drug developers and act as a deterrent, especially in cases where clinical benefits may not justify high development costs. This risk-benefit assessment by companies has at times stalled progress and restrained growth of the drug delivery market.

Market Opportunity: Nanotechnology Applications

The expanding applications of nanotechnology in the design and engineering of drug delivery systems provide huge growth opportunities. Nanocarriers such as liposomes, polymeric nanoparticles, metallic nanoparticles etc. allow for targeted transport and controlled release of pharmaceutical actives. They help overcome numerous limitations of traditional delivery and improve therapeutic outcomes. Continuous advancements are being made through nano-enabled formulations like nanosuspensions, dendrimers, solid lipid nanoparticles etc. Substantial R&D investments by industry players as well as government agencies have accelerated nanotechnology development. Its enormous potential to resolve problems in drug solubility, stability, toxicity and lack of specificity is expected to revolutionize the drug delivery landscape in the coming years.

Market Trend: Intelligent and Responsive Delivery Systems

A key emerging trend in the drug delivery field is the development of intelligent and responsive delivery platforms. These incorporate sensing and feedback mechanisms to detect physiological/environmental changes and release drugs accordingly for optimal therapeutic effects. Examples include pH-, temperature-, enzyme- or glucose-responsive hydrogels and nanoparticles. Implantable drug delivery systems are being integrated with biosensors for real-time monitoring and automaticdose adjustments. Smart delivery technologies allow personalized treatment regimens and help improve medication adherence. They reduce toxicity risks from over/under-dosing of drugs. Advancements in materials, microfabrication, bioengineering, device miniaturization and data analytics are enabling a new generation of intelligent delivery systems with significant commercial potential.

Furthermore, the years considered for the study are as follows:

Historical data - 2016-2022
The base year for estimation - is 2022
Estimated Year - 2024
Forecast period** - 2024 to 2031

Buy This Premium Report and Get Upto 25 % OFF: https://www.coherentmarketinsights.com/insight/buy-now/2690

This Drug Delivery Technologies Market Research/Analysis Report Contains Answers to your following Questions:

◈What are the current global trends in the Drug Delivery Technologies market, and will the market experience an increase or decrease in demand in the upcoming years?

◈ What is the expected demand for various product types within the Drug Delivery Technologies market, and what are the emerging Market applications and trends?

◈ What are the projections for the global Drug Delivery Technologies Market in terms of capacity, production, production value, cost, profit, market share, supply, consumption, import, and export?

◈ How will strategic developments shape the Market trajectory in the medium to long term?

◈ What factors contribute to the final price of Drug Delivery Technologies , and what are the raw materials used in its manufacturing?

◈ What is the market's growth potential, particularly with the increasing adoption of Drug Delivery Technologies in mining?

◈ What is the current and 2022 value of the global market, and who are the leading companies in this market?

◈ What recent Market trends can be leveraged to create additional revenue streams?

◈ What entry strategies, economic impact mitigation measures, and marketing channels should be considered for the Drug Delivery Technologies Market?

We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/2690

Summarized Extracts from TOC of Market Study

Chapter 1 Drug Delivery Technologies Introduction and Market Overview

1.1 Objectives of the Study

1.2 Overview of Drug Delivery Technologies

1.3 Scope of The Study

1.3.1 Key Market Segments

1.3.2 Players Covered

1.3.3 COVID-19's impact on the Drug Delivery Technologies industry

1.4 Methodology of The Study

1.5 Research Data Source

Chapter 2 Executive Summary

Chapter 3 Industry Chain Analysis

Chapter 4 Market, by Type

Chapter 5 Market, by Application

Chapter 6 Market Analysis by Regions

Chapter 7 North America Market Analysis by Countries

Chapter 8 Europe Drug Delivery Technologies Market Analysis by Countries

Chapter 9 Asia Pacific Drug Delivery Technologies Market Analysis by Countries

Chapter 10 Middle East and Africa Drug Delivery Technologies Market Analysis by Countries

Chapter 11 South America Drug Delivery Technologies Market Analysis by Countries

Chapter 12 Competitive Landscape

Chapter 13 Industry Outlook

Chapter 14 Market Forecast

Chapter 15 New Project Feasibility Analysis

Contact Us

Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States
Phone: US +12067016702 / UK +4402081334027
JAPAN:+81-50-5539-1737
INDIA:+91-848-285-0837
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Delivery Technologies Market Growth Factors 2024, Demand Supply Scenario, Size Estimates, Competitive Analysis and Forecast to 2031 | Glaxosmithkline PLC, Vectura Group Plc here

News-ID: 3503379 • Views:

More Releases from Coherent Market Insights

Challenges and Future Growth Analysis of Cold Pain Therapy Market 2024 Scenario, Industry Analysis by Revenue, Size, Share and Forecast | CryoConcepts LP, Metrum Cryoflex, Brymill Cryogenic Systems, Mectronic Mediccale S.r.l.
Challenges and Future Growth Analysis of Cold Pain Therapy Market 2024 Scenario, …
A new report titled "Cold Pain Therapy Market" Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. The report features a comprehensive table of contents, figures, tables, and charts, as well as insightful analysis. The keyword market has been expanding
Cell Expansion Market Experience Massive Growth |Becton, Dickinson and Company, Sartorius AG, Merck KGaA
Cell Expansion Market Experience Massive Growth |Becton, Dickinson and Company, …
A new report titled "Cell Expansion Market" Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. The report features a comprehensive table of contents, figures, tables, and charts, as well as insightful analysis. The keyword market has been expanding significantly
Empowering Growth: Precision Medicine Diagnostics Market 2024 Opportunities, Emerging Trends, Forecast Till 2031 |Ferrer Incode, Nanostring Technologies, Inc., Tepnel Pharma Services
Empowering Growth: Precision Medicine Diagnostics Market 2024 Opportunities, Eme …
A new report titled "Precision Medicine Diagnostics Market" Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. The report features a comprehensive table of contents, figures, tables, and charts, as well as insightful analysis. The keyword market has been expanding
Bioresorbable Implants Market Expected to Expand at a Steady 2024-2031 |Bioretec Ltd., CONMED Corporation, Depuy Synthes, Stryker Corporation
Bioresorbable Implants Market Expected to Expand at a Steady 2024-2031 |Bioretec …
A new report titled "Bioresorbable Implants Market" Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. The report features a comprehensive table of contents, figures, tables, and charts, as well as insightful analysis. The keyword market has been expanding significantly

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug